Holen Sie sich die Stockscreener-App
5.7499
5.06%
-0.3065
Handel nachbörslich:
5.77
0.0201
+0.35%
Schlusskurs vom Vortag:
$6.0564
Offen:
$5.76
24-Stunden-Volumen:
9,895
Relative Volume:
0.41
Marktkapitalisierung:
$211.49M
Einnahmen:
$7.80M
Nettoeinkommen (Verlust:
$-69.02M
KGV:
-2.851
EPS:
-2.0168
Netto-Cashflow:
$-66.61M
1W Leistung:
-7.26%
1M Leistung:
+14.54%
6M Leistung:
+44.47%
1J Leistung:
+24.46%
1-Tages-Spanne:
$5.67
$6.0384
1-Wochen-Bereich:
$5.30
$6.25
52-Wochen-Spanne:
$3.32
$12.70
Molecular Partners Ag Adr Stock (MOLN) Company Profile
Firmenname
Molecular Partners Ag Adr
Sektor
Branche
Telefon
-
Adresse
-
Molecular Partners Ag Adr Stock (MOLN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-30 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-08-29 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-05-25 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2022-04-27 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-07-13 | Eingeleitet | Cowen | Outperform |
| 2021-07-12 | Fortgesetzt | SVB Leerink | Outperform |
Alle ansehen
Molecular Partners Ag Adr Aktie (MOLN) Neueste Nachrichten
Molecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M - TipRanks
Molecular Partners, Orano Med announce presentation of MP0712 data - TipRanks
Molecular Partners expands 212Pb co-development agreement with Orano Med - TipRanks
Molecular Partners shares gain on Leerink's outperform rating - Investing.com
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga
Wall Street Analysts See a 96% Upside in Molecular Partners AG Sponsored ADR (MOLN): Can the Stock Really Move ... - Yahoo News UK
Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit - GlobeNewswire Inc.
Molecular Partners' New Therapy Shows AML Treatment PromiseTipRanks.com - TipRanks
Molecular Partners Unveils Promising Cancer Therapy - TipRanks
Why GameStop Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket By Benzinga - Investing.com UK
Molecular Partners Shares Rise on Positive Trial Data for MP0317 - MarketWatch
Novartis (NVS) & Molecular Partners Initiate Study for COVID-19 - Yahoo Singapore News
Rigel Pharmaceuticals names new Chief Medical Officer By Investing.com - Investing.com
Molecular Partners: Sellers Have Disappeared, Enterprise Value Below Zero (NASDAQ:MOLN) - Seeking Alpha
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.19% - Investing.com UK
US stock market gainers for the last week of April 2022 - Nairametrics
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.45% - Investing.com India
The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOsiShares Biote - Benzinga
Molecular Partners (MLLCF) Stock Price, News & Analysis - MarketBeat
Market Data Center - Barron's
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Finanzdaten der Molecular Partners Ag Adr-Aktie (MOLN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):